Actively Recruiting
Effects of Menstrual Cycle-based Undulating Periodized Resistance Training in Women's Neuromuscular Abilities
Led by Universite de La Reunion · Updated on 2024-11-07
60
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
Sponsors
U
Universite de La Reunion
Lead Sponsor
P
Physio Formation
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating how resistance training adjusted to menstrual cycle phases affects neuromuscular function in female athletes. The study focuses on whether training intensity changes aligned with menstrual phases improve maximal knee extensor strength and other neuromuscular measures like voluntary activation, rate of force development, muscle stiffness, and vertical jump height. The trial compares female athletes with natural menstrual cycles to those using oral contraceptives to understand hormonal influences on training adaptations. Participants are assigned to one of four groups: three with natural menstrual cycles receiving different resistance training intensities either intensified during the follicular phase, luteal phase, or continuous training across all phases, and a control group of oral contraceptive users undergoing continuous intensity training. Each group completes a 13-week resistance training program with two 90-minute sessions per week, with intensity modulated according to the menstrual cycle phase or contraceptive use. Throughout the study, participants undergo neuromuscular evaluations before and after the training period across the early follicular, late follicular, and mid-luteal phases. Assessments include maximal knee extensor strength, muscle activation, rate of force development, muscle stiffness, and vertical jump height. Blood samples verify hormone levels during testing. The study aims to provide insights for optimizing training based on menstrual phases to improve performance and neuromuscular health in female athletes.
CONDITIONS
Brief Title
Impact of Menstrual Cycle-Based Resistance Training on Neuromuscular Performance in Female Athletes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female athletes with natural menstrual cycles lasting 21 to 35 days and at least 9 cycles per year
- Women using a low-dose monophasic estrogen-progestin oral contraceptive
- Age 18 years or older
- Body Mass Index between 18 and 30 kg/m²
- No medical contraindications to high-level physical training or exercise
- Physically active with at least 3 hours of physical activity per week
- Provides written informed consent to participate
- Affiliated with a social security system (if applicable)
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 13 weeks
Participants complete a 13-week structured resistance training program tailored to their group, involving two 90-minute sessions per week. Training intensity varies by group and menstrual cycle phase, including intensified training during the follicular phase, luteal phase, or continuous intensity throughout the cycle.
Two training sessions per week
Duration - Assessments occur pre- and post-intervention over the course of the study
Participants undergo neuromuscular testing and blood sampling for hormonal verification before and after the training program during three menstrual phases: early follicular, late follicular, and mid-luteal. These assessments measure muscle strength, activation, stiffness, and jump performance.
6 assessment visits (3 pre-intervention and 3 post-intervention)
Trial Site Locations
Total: 1 location
1
Laboratoire IRISSE (Université de La Réunion)
Le Tampon, France, Reunion, 97430
Actively Recruiting
Research Team
M
Manon DAUVERGNE, PhD student
J
Josué GAN, Msc.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
4
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here